Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, womenâ€™s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.

Employees

Sector

Pharmaceuticals

More about the company

End-of-day quote Bratislava S.E. 2026-10-29			5-day change	1st Jan Change
33.20 ^EUR	-.--%		-.--%	+10.67%

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE

Market Cap	243M 218M 199M 182M 343M 22.85B 353M 2.4B 957M 12.19B 912M 893M 38.48B	P/E 2017	7.27x	P/E 2018	177x
Enterprise Value	242M 217M 199M 181M 342M 22.77B 352M 2.39B 954M 12.15B 909M 890M 38.36B	EV / Sales 2017	3.97x	EV / Sales 2018	11.2x
Free-Float	4.05%	Yield 2017	13.8%	Yield 2018	-

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-11	Zentiva announces sale from Advent to GTCR	RE
25-09-11	Private equity firm Advent to sell drugmaker Zentiva to GTCR	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-10	Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports	RE
25-09-10	Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports	RE
25-09-10	Advent strikes EUR4.1bn deal to sell generic drugmaker Zentiva to GTCR - FT	RE
25-08-20	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
25-08-20	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
13-02-20	Wood Pharma Holding a.s. completed the acquisition of Hlohovec Production Plant from Zentiva A.S..	CI

1 month	+7.10%
3 months	+7.10%
6 months	+10.67%
Current year	+10.67%

Zentiva, Stock

Stocks

1SKF401E

SK1120004439

Pharmaceuticals

Valuation: Zentiva,

Chart: Zentiva,

Latest news: Zentiva,

Press Releases: Zentiva,

Quotes and Performance

Price Extremes

Managers and Directors: Zentiva,

Generic Pharmaceuticals

Financials

Company Profile

1 month	31	33.2
Current year	29	33.2
1 year	29	33.2
3 years	24	45
5 years	24	45
10 years	11	370

Manager	Title	Age	Since
Thomas Cornelis Koene CEO	Chief Executive Officer	-	2015-11-11
Hacho Agop Hatchikian PRN	Corporate Officer/Principal	-	2022-08-17

Director	Title	Age	Since
Kenneth Lynard BRD	Director/Board Member	58	2020-11-14
Mojmír Krutý BRD	Director/Board Member	-	2013-07-07
Martin Albert BRD	Director/Board Member	-	2018-10-17

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZENTIVA,	-.--%	-.--%	-26.22%	+10.67%	59.97M
ELI LILLY AND COMPANY	-0.79%	-4.48%	+46.48%	+125.69%	1,206B
JOHNSON & JOHNSON	+1.43%	+1.11%	+48.05%	+83.05%	665B
ABBVIE INC.	+1.07%	-1.21%	+32.92%	+104.92%	515B
ROCHE HOLDING AG	-0.36%	-3.25%	+45.42%	+65.10%	381B
MERCK & CO., INC.	-0.14%	-1.87%	+70.06%	+41.09%	362B
NOVARTIS AG	-0.78%	-0.52%	+30.47%	+58.09%	307B
ASTRAZENECA PLC	-0.80%	-0.21%	+7.98%	+36.17%	289B
AMGEN INC.	+0.03%	-1.20%	+43.79%	+69.83%	249B
GILEAD SCIENCES, INC.	-0.41%	-2.22%	+40.43%	+107.03%	207B
Average	-0.08%	-0.68%	+33.94%	+70.16%	417.98B
Weighted average by Cap.	-0.04%	-1.96%	+42.71%	+88.11%

	2017	2018
Net sales	143M 128M 117M 107M 201M 13.41B 207M 1.41B 562M 7.16B 536M 524M 22.59B	36.17M 32.44M 29.65M 27.07M 51M 3.4B 52.6M 357M 143M 1.81B 136M 133M 5.73B
Net income	77.98M 69.94M 63.92M 58.35M 110M 7.33B 113M 770M 307M 3.91B 293M 286M 12.35B	2.29M 2.05M 1.88M 1.71M 3.23M 215M 3.33M 22.63M 9.02M 115M 8.6M 8.41M 363M
Net Debt	-0.09 -0.08 -0.08 -0.07 -0.13 -8.65 -0.13 -0.91 -0.36 -4.61 -0.35 -0.34 -14.57	-0.77 -0.69 -0.63 -0.58 -1.09 -72.76 -1.13 -7.65 -3.05 -38.82 -2.91 -2.84 -122.56